Connection

JASVINDER SINGH to Chronic Disease

This is a "connection" page, showing publications JASVINDER SINGH has written about Chronic Disease.
Connection Strength

0.861
  1. Gout: will the "King of Diseases" be the first rheumatic disease to be cured? BMC Med. 2016 Nov 11; 14(1):180.
    View in: PubMed
    Score: 0.097
  2. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28; 386(10009):2145-91.
    View in: PubMed
    Score: 0.089
  3. Patient-centered priorities for improving medication management and adherence. Patient Educ Couns. 2015 Jan; 98(1):102-10.
    View in: PubMed
    Score: 0.084
  4. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14; 310(6):591-608.
    View in: PubMed
    Score: 0.078
  5. Medical comorbidity is associated with persistent index hip pain after total hip arthroplasty. Pain Med. 2013 Aug; 14(8):1222-9.
    View in: PubMed
    Score: 0.077
  6. Emerging therapies for gout. Expert Opin Emerg Drugs. 2012 Dec; 17(4):511-8.
    View in: PubMed
    Score: 0.074
  7. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011 Jul; 70(7):1277-81.
    View in: PubMed
    Score: 0.067
  8. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011 Jul; 38(7):1452-7.
    View in: PubMed
    Score: 0.067
  9. Pegloticase for chronic gout. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008335.
    View in: PubMed
    Score: 0.061
  10. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152669.
    View in: PubMed
    Score: 0.043
  11. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 Jul; 39(7):1450-7.
    View in: PubMed
    Score: 0.018
  12. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol. 2011 Jul; 38(7):1458-61.
    View in: PubMed
    Score: 0.017
  13. Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol. 2011 Jul; 38(7):1462-6.
    View in: PubMed
    Score: 0.017
  14. Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol. 2011 Jul; 38(7):1467-70.
    View in: PubMed
    Score: 0.017
  15. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009 Oct; 36(10):2342-5.
    View in: PubMed
    Score: 0.015
  16. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 2009 Oct; 36(10):2346-55.
    View in: PubMed
    Score: 0.015
  17. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008 Jun; 67(6):888-91.
    View in: PubMed
    Score: 0.013
  18. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol. 2006 Jun; 81(6):432-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.